股息配發率   玩股撇步(動畫小學堂)

  • 現金殖利率: 4.46%、總殖利率: 4.46%、5年平均現金配發率: 99.23%
  • 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
  • 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY現金股利 YoY股票股利 YoY現金配發率 YoY股票配發率 YoY全部配發率 YoY
2023 (10)-1.1301.00100.00.0000.0000.0000.000
2022 (9)0.66-74.420.50-66.670.00075.7630.30.00075.7630.3
2021 (8)2.58-84.721.50-85.00.00058.14-1.860.00058.14-1.86
2020 (7)16.882457.5810.00400.00.00059.24-80.450.00059.24-80.45
2019 (6)0.66100.02.00300.00.000303.03100.00.000303.03100.0
2018 (5)0.336.450.5066.670.000151.5256.570.000151.5256.57
2017 (4)0.31-63.10.30-40.00.00096.7762.580.00096.7762.58
2016 (3)0.84-47.50.50-64.290.00059.52-31.970.00059.52-31.97
每股盈餘-近20季
EPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY
24Q3 (20)-0.19-111.1117.39-0.2020.060.0-0.54-54.2928.0
24Q2 (19)-0.0965.3850.0-0.2547.920.0-0.35-34.6232.69
24Q1 (18)-0.2631.5821.21-0.48-77.78-33.33-0.2676.9921.21
23Q4 (17)-0.38-65.22-850.0-0.2746.0-440.0-1.13-50.67-271.21
23Q3 (16)-0.23-27.78-154.76-0.50-100.0-354.55-0.75-44.23-207.14
23Q2 (15)-0.1845.45-185.71-0.2530.56-56.25-0.52-57.58-285.71
23Q1 (14)-0.33-725.0-571.43-0.36-620.0-125.0-0.33-150.0-571.43
22Q4 (13)-0.04-109.52-113.33-0.0554.55-125.00.66-5.71-74.62
22Q3 (12)0.42100.02200.0-0.1131.25-57.140.70150.0-69.57
22Q2 (11)0.21200.0-74.39-0.160.0-113.790.28300.0-87.93
22Q1 (10)0.07-76.67-95.33-0.16-180.0-111.030.07-97.31-95.33
21Q4 (9)0.301600.0-87.230.20385.71-92.342.6013.04-84.71
21Q3 (8)-0.02-102.44-100.5-0.07-106.03-101.652.30-0.86-84.31
21Q2 (7)0.82-45.33-88.321.16-20.0-83.482.3254.67-78.28
21Q1 (6)1.50-36.17-59.021.45-44.44-59.381.50-91.18-59.02
20Q4 (5)2.35-40.951282.352.61-38.59944.017.0116.032477.27
20Q3 (4)3.98-43.30.04.25-39.460.014.6637.270.0
20Q2 (3)7.0291.80.07.0296.640.010.68191.80.0
20Q1 (2)3.662052.940.03.571328.00.03.66454.550.0
19Q4 (1)0.170.00.00.250.00.00.660.00.0
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/100.33-12.114.773.34-3.671.05N/A-
2024/90.375.2823.043.01-4.511.074.64-
2024/80.352.127.92.64-7.421.04.94-
2024/70.3513.116.742.29-9.410.985.07-
2024/60.31-6.64-0.641.94-11.781.064.63-
2024/50.33-24.268.061.64-13.591.074.6-
2024/40.4337.5433.131.31-17.70.995.0-
2024/30.3130.51-7.880.88-30.70.885.79-
2024/20.24-25.84-34.390.56-39.090.945.42-
2024/10.32-13.32-42.160.32-42.161.044.88-
2023/120.378.26-16.164.18-25.871.034.89-
2023/110.3510.98-21.853.81-26.70.965.26-
2023/100.313.2-22.343.47-27.150.945.36-
2023/90.3-7.66-26.323.15-27.590.955.68-
2023/80.331.02-35.02.85-27.720.965.65-
2023/70.325.27-46.632.53-26.660.935.8-
2023/60.311.54-48.952.2-22.40.935.73-
2023/50.3-6.69-58.331.89-15.250.975.53本月較去年同期減少,主係因出貨量減少所致
2023/40.32-4.83713.061.595.451.035.19本月營收較去年同期增加,主係去年同期生產基地昆山熱映因配合當地政府新冠肺炎防疫措施停工停產導致去年同期基期偏低所致
2023/30.34-7.04-32.431.27-13.731.274.42-
2023/20.37-34.63-11.590.93-3.971.374.08-
2023/10.5625.641.740.561.741.453.86-
2022/120.450.91-28.055.65-42.681.294.5-
2022/110.4410.29-26.735.2-43.671.254.63-
2022/100.4-2.08-24.454.76-44.851.314.42-
2022/90.41-18.54-18.584.36-46.191.523.93-
2022/80.5-17.040.333.95-48.021.713.48-
2022/70.610.690.223.44-51.431.933.08本年累計較去年同期減少,主係因出貨量減少所致
2022/60.6-17.1-20.952.84-56.251.374.25本年累計較去年同期減少,主係因出貨量減少所致
2022/50.731720.66-19.752.24-60.941.274.57本年累計較去年同期減少,主係因出貨量減少所致
2022/40.04-92.09-96.031.51-68.680.966.06本月營收較去年同期減少,主係生產基地昆山熱映因配合當地政府新冠肺炎防疫措施,停工停產,4月份九成以上訂單遞延至5月出貨
2022/30.521.62-51.041.47-61.471.474.12本月較去年同期減少,主係因出貨量減少所致
2022/20.41-24.76-60.560.97-65.331.593.82本月較去年同期減少,主係因出貨量減少所致
2022/10.55-11.16-68.220.55-68.221.783.41本月較去年同期減少,主係因出貨量減少所致
2021/120.622.77-69.989.85-62.351.753.23本月較去年同期減少,主係因出貨量減少所致
2021/110.613.72-77.99.23-61.71.643.46本月較去年同期減少,主係因出貨量減少所致
2021/100.535.52-79.668.63-59.621.533.69本月較去年同期減少,主係因出貨量減少所致
2021/90.50.38-79.158.1-56.841.613.44本月較去年同期減少,主係因出貨量減少所致
2021/80.5-17.13-77.287.59-53.541.872.97本月較去年同期減少,主係因出貨量減少所致
2021/70.6-20.58-78.437.09-49.842.272.44本月較去年同期減少,主係因出貨量減少所致
2021/60.76-15.85-72.056.49-42.772.671.94本月較去年同期減少,主係因出貨量減少所致
2021/50.9-9.97-64.835.73-33.52.941.77本月較去年同期減少,主係因出貨量減少所致
2021/41.01-2.41-52.334.82-20.143.091.68本月較去年同期減少,主係因出貨量減少所致
2021/31.03-2.04-49.363.82-2.873.821.39-
2021/21.05-39.36-15.512.7947.034.851.09-
2021/11.73-16.1166.811.73166.816.530.81本公司體溫量測相關產品供應全球新冠肺炎防疫所需,帶動企業營收成長。
2020/122.07-24.31223.6626.17233.377.410.74本公司體溫量測相關產品供應全球新冠肺炎防疫所需,帶動企業營收成長。
2020/112.734.64288.5724.1234.237.750.71本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/102.618.15317.6721.37228.367.230.76本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/92.419.41218.1118.76218.877.420.73本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/82.21-21.35213.316.35218.987.730.7本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/72.82.91330.8414.14219.898.10.67本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求持續強勁,帶動企業營收顯著成長。
2020/62.725.87285.9711.34200.737.410.48本公司額耳溫槍等體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求持續強勁,帶動企業營收顯著成長。
2020/52.5722.04243.088.61181.096.720.53本公司額/耳溫槍等體溫量測產品供應全球新冠肺炎防疫所需,海外市場需求強勁,持續帶動企業營收顯著成長。
2020/42.113.65212.886.04160.995.390.66本公司為加速因應全球新冠肺炎防疫需求,以自有品牌額/耳溫槍等體溫量測產品,供應國內外市場需求,進而帶動企業營收顯著成長。
2020/32.0363.43238.563.93139.653.930.71新冠肺炎疫情全球持續延燒,國內外因應防疫所需,對本公司自有品牌體溫量測產品需求強勁,進而帶動企業營收顯著成長。
2020/21.2491.48200.261.8982.432.531.1由於新冠肺炎疫情延燒,因應防疫所需,對體溫量測產品需求強勁,帶動本公司營收成長。
2020/10.651.774.160.654.161.991.4-
2019/120.64-9.14-5.657.85-3.710.0N/A-
2019/110.712.484.487.21-3.530.0N/A-

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。